The Reports and Insights, a leading market research company, has recently releases report titled “Antimicrobial Susceptibility Testing Market Share: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global Antimicrobial Susceptibility Testing Market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights:
How big is the Antimicrobial Susceptibility Testing Market?
The antimicrobial susceptibility testing market was valued at US$ 3.7 Billion in 2023, and is expected to register a CAGR of 5.7% over the forecast period and reach US$ 6.1 Bn in 2032.
What are Antimicrobial Susceptibility Testing?
Antimicrobial susceptibility testing (AST) is a laboratory method that assesses the effectiveness of particular antimicrobial agents against bacteria or fungi obtained from a patient's sample. It aids in selecting the best treatment by determining which antibiotics are likely to work. AST findings are essential for clinicians to choose the most appropriate antimicrobial therapy, particularly in cases involving drug-resistant pathogens. Standardized methods are used for the test to ensure its accuracy and reliability, providing critical information for personalized and effective patient management.
Request for a sample copy with detail analysis: https://www.reportsandinsights.com/sample-request/2306
What are the growth prospects and trends in the Antimicrobial Susceptibility Testing industry?
The antimicrobial susceptibility testing (AST) market growth is driven by various factors and trends. The market for antimicrobial susceptibility testing (AST) includes various products and services aimed at assisting healthcare providers in determining the most suitable antimicrobial treatment for bacterial and fungal infections. This market comprises testing kits, automated systems, and software for analyzing microbial susceptibility patterns. Growth in this market is fueled by the increasing prevalence of drug-resistant pathogens, which has heightened the demand for accurate and rapid AST methods. Technological advancements, such as multiplexed and automated systems, are also driving market expansion. Furthermore, the growing awareness of the importance of antimicrobial stewardship programs in healthcare settings is expected to further boost market growth as healthcare facilities aim to optimize antibiotic use and combat antimicrobial resistance. Hence, all these factors contribute to antimicrobial susceptibility testing (AST) market growth.
What is included in market segmentation?
The report has segmented the market into the following categories:
Antimicrobial Susceptibility Testing Market Segmentation:
By Product Type
- Automated AST Systems
- Manual AST Products
- Consumables
- Antibiotic Discs
- Plates
- Broth
- Accessories
- Inoculating Loops
- Spreaders
- Services and Software
By Method
- Disk Diffusion
- Broth Dilution
- E-test
- Molecular Testing
- Polymerase Chain Reaction (PCR)
- Sequencing
By Application
- Clinical Diagnostics
- Drug Development and Research
- Epidemiology and Surveillance
- Veterinary Diagnostics
By End User
- Hospitals and Clinics
- Diagnostic Laboratories
- Pharmaceutical and Biotechnology Companies
- Research Institutes and Academic Centers
By Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Russia
- Poland
- Benelux
- Nordic
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- ASEAN
- Australia & New Zealand
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Argentina
Middle East & Africa
- Saudi Arabia
- South Africa
- United Arab Emirates
- Israel
- Rest of ME
Who are the key players operating in the industry?
The report covers the major market players including:
- BD (Becton, Dickinson and Company)
- Synbiosis
- Zhuhai DL Biotech Co., Ltd
- Mast Group Ltd.
- HiMedia Laboratories
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- Creative Diagnostics
- Genefluidics, Inc.
- Rosco Diagnostica A/S
- ERBA Group
- Liofilchem S.r.l.
- Alifax S.r.l.
- MERLIN Gesellschaft für mikrobiologische Diagnostika mbH
- bioMérieux SA
View Full Report: https://www.reportsandinsights.com/report/antimicrobial-susceptibility-testing-market
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
Reports and Insights consistently mееt international benchmarks in the market research industry and maintain a kееn focus on providing only the highest quality of reports and analysis outlooks across markets, industries, domains, sectors, and verticals. We have bееn catering to varying market nееds and do not compromise on quality and research efforts in our objective to deliver only the very best to our clients globally.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
Reports and Insights Business Research Pvt. Ltd.
1820 Avenue M, Brooklyn, NY, 11230, United States
Contact No: +1-(347)-748-1518
Email: sales@reportsandinsights.com
Website: https://www.reportsandinsights.com/
Follow us on LinkedIn: https://www.linkedin.com/company/report-and-insights/
Follow us on twitter: https://twitter.com/ReportsandInsi1
